A significant update to the 2010 publications on the Diagnosis and management of Duchenne muscular dystrophy was published in The Lancet Neurology, in 2018. These new care considerations address the needs of patients with prolonged survival, offer guidance on assessments and interventions, and consider the implications of emerging therapies for Duchenne Muscular Dystrophy (DMD).
Part 1: Diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.
Part 2: Respiratory, cardiac, bone health, and orthopaedic management
Part 3: Primary care, emergency management, psychosocial care, and transitions of care across the lifespan
